About Zevacor
Zevacor is a company based in Dulles (United States) founded in 2013 was acquired by Curium in March 2020. Zevacor operates in a competitive market with competitors including ImaginAb, AC Immune, APRINOIA, BioTelemetry and Innovate Biopharma, among others.
- Headquarter Dulles, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Zevacor
Unlock access to complete
Unlock access to complete
Funding Insights of Zevacor
Detailed funding history for Zevacor
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Zevacor
Zevacor has secured backing from 2 investors. Prominent investors backing the company include SOFIE and Curium Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Curium Pharma is recognized as a leader in radiopharmaceuticals.
|
Locked | Locked | Locked | |
|
Developer of molecular imaging systems and radio-pharmaceuticals
|
Locked | Locked | Locked |
Investor details for Zevacor
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Zevacor
Investment portfolio details for Zevacor
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Zevacor
Detailed financials for Zevacor
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Zevacor Comparisons
Peer comparison for Zevacor
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Zevacor
Zevacor operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ImaginAb, AC Immune, APRINOIA, BioTelemetry and Innovate Biopharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
ImaginAb is focused on developing advanced immuno-oncology imaging technologies.
|
|
| Locked | Locked | Locked |
Antibodies, small molecules, and vaccines are developed for neurodegenerative diseases.
|
|
| Locked | Locked | Locked |
Diagnostics and therapeutics for neurodegenerative disorders are developed.
|
|
| Locked | Locked | Locked |
Wireless products for monitoring health parameters are offered.
|
|
| Locked | Locked | Locked |
Small molecule drugs and imaging agent for GI disorders
|
|
| Locked | Locked | Locked |
Imaging compounds & targeted radiotherapies to detect and treat prostate cancer.
|
Detailed competitors of Zevacor
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Zevacor
Complete news archive for Zevacor
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zevacor
Zevacor was founded in 2013.
Zevacor is headquartered in Dulles, United States. It is registered at Dulles, Virginia, United States.
Zevacor is focussed on developing radiopharmaceutical products and supporting services for use in nuclear medicine and molecular imaging. It provides its services through its subsidiaries Zevacor Pharma and Zevacor Molecular formerly IBA Molecular). Zevacor Molecular manufactures PET and SPECT radiopharmaceuticals and is working on the construction of a new 70 MeV cyclotron and multiple synthesis and processing units for production and distribution of a broad range of clinical and research radioisotopes. Zevacor Pharma provides investigative and custom radiolabeling services to pharmaceutical, biotech, and research institutions nationwide for the development of the next generation of molecular imaging and therapeutic products.
Zevacor has 2 investors. Key investors include SOFIE, and Curium Pharma.